PMID- 28738056
OWN - NLM
STAT- MEDLINE
DCOM- 20180508
LR  - 20180508
IS  - 1538-067X (Electronic)
IS  - 1092-1095 (Linking)
VI  - 21
IP  - 4 Suppl
DP  - 2017 Aug 1
TI  - Advances in Melanoma: The Rationale for the Melanoma Nursing Initiative
.
PG  - 7-10
LID - 10.1188/17.CJON.S4.7-10 [doi]
AB  - This article provides an overview of this supplement, outlining the needs 
      assessment process the Melanoma Nursing Initiative (MNI) used to determine the 
      immunotherapy and targeted therapy topics for discussion as well as the process 
      for developing the consensus statements. The article provides specific discussion 
      of a unique feature of the MNI, the care step pathways (CSPs) for management of 
      adverse events (AEs) associated with melanoma therapies, and looks to the future 
      in terms of the potential benefits of engaging and enabling oncology nurses to 
      adopt a standardized approach to AE management and adherence promotion for 
      melanoma therapies.
FAU - Rubin, Krista M
AU  - Rubin KM
AD  - Massachusetts General Hospital Cancer Center.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Clin J Oncol Nurs
JT  - Clinical journal of oncology nursing
JID - 9705336
MH  - Education, Nursing, Continuing
MH  - Guideline Adherence
MH  - Humans
MH  - Immunotherapy
MH  - Melanoma/*nursing/therapy
OTO - NOTNLM
OT  - Melanoma Nursing Initiative
OT  - adherence
OT  - implementation
OT  - melanoma
OT  - nursing
OT  - toxicity
EDAT- 2017/07/25 06:00
MHDA- 2018/05/09 06:00
CRDT- 2017/07/25 06:00
PHST- 2017/07/25 06:00 [entrez]
PHST- 2017/07/25 06:00 [pubmed]
PHST- 2018/05/09 06:00 [medline]
AID - 10.1188/17.CJON.S4.7-10 [doi]
PST - ppublish
SO  - Clin J Oncol Nurs. 2017 Aug 1;21(4 Suppl):7-10. doi: 10.1188/17.CJON.S4.7-10.